Form 8-K - Current report:
SEC Accession No. 0001193125-25-002629
Filing Date
2025-01-07
Accepted
2025-01-07 09:05:31
Documents
15
Period of Report
2025-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d885819d8k.htm   iXBRL 8-K 42703
2 EX-99.1 d885819dex991.htm EX-99.1 20129
6 GRAPHIC g885819g59z50.jpg GRAPHIC 2875
  Complete submission text file 0001193125-25-002629.txt   195337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20250107.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20250107_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20250107_pre.xml EX-101.PRE 10821
17 EXTRACTED XBRL INSTANCE DOCUMENT d885819d8k_htm.xml XML 3498
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 25513573
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)